Literature DB >> 32003929

Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.

Annayya R Aroor1,2,3, Adam Whaley-Connell1,2,3,4,5, James R Sowers1,2,3,5,6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32003929      PMCID： PMC8029767          DOI： 10.1111/jch.13817

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  20 in total

Review 1.  Metabolic Syndrome: Bridging the Gap from Childhood to Adulthood.

Authors:  Mehmet Agirbasli; Azra M Tanrikulu; Gerald S Berenson
Journal:  Cardiovasc Ther       Date:  2016-02       Impact factor: 3.023

Review 2.  Arterial stiffness and pulse pressure in CKD and ESRD.

Authors:  Marie Briet; Pierre Boutouyrie; Stéphane Laurent; Gérard M London
Journal:  Kidney Int       Date:  2012-08       Impact factor: 10.612

Review 3.  Determinants and Prognostic Significance of the Renal Resistive Index.

Authors:  Nicholas Cauwenberghs; Tatiana Kuznetsova
Journal:  Pulse (Basel)       Date:  2016-01-09

4.  Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice.

Authors:  Annayya R Aroor; Guanghong Jia; Javad Habibi; Zhe Sun; Francisco I Ramirez-Perez; Barron Brady; Dongqing Chen; Luis A Martinez-Lemus; Camila Manrique; Ravi Nistala; Adam T Whaley-Connell; Vincent G Demarco; Gerald A Meininger; James R Sowers
Journal:  Metabolism       Date:  2017-06-21       Impact factor: 8.694

Review 5.  Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity?

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2017-09-30       Impact factor: 2.041

Review 6.  Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes.

Authors:  Claudia R L Cardoso; Gil F Salles
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

7.  The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.

Authors:  Javad Habibi; Annayya R Aroor; Nitin A Das; Camila M Manrique-Acevedo; Megan S Johnson; Melvin R Hayden; Ravi Nistala; Charles Wiedmeyer; Bysani Chandrasekar; Vincent G DeMarco
Journal:  Cardiovasc Diabetol       Date:  2019-03-25       Impact factor: 9.951

Review 8.  Chronic Kidney Disease and Pulse Wave Velocity: A Narrative Review.

Authors:  Nicole Lioufas; Carmel M Hawley; James D Cameron; Nigel D Toussaint
Journal:  Int J Hypertens       Date:  2019-02-17       Impact factor: 2.420

9.  Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.

Authors:  Annayya R Aroor; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

10.  The relationship between renal resistive index, arterial stiffness, and atherosclerotic burden: the link between macrocirculation and microcirculation.

Authors:  Jordi Calabia; Pere Torguet; Isabel Garcia; Nadia Martin; Gerard Mate; Adriana Marin; Carolina Molina; Marti Valles
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-19       Impact factor: 3.738
View more
  2 in total

1.  Renal resistive index as a novel biomarker for cardiovascular and kidney risk reduction in type II diabetes.

Authors:  Annayya R Aroor; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

Review 2.  The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Michele Provenzano; Michele Andreucci; Luca De Nicola; Carlo Garofalo; Yuri Battaglia; Silvio Borrelli; Ida Gagliardi; Teresa Faga; Ashour Michael; Pasquale Mastroroberto; Giuseppe Filiberto Serraino; Noemi Licastro; Nicola Ielapi; Raffaele Serra
Journal:  Biomed Res Int       Date:  2020-10-08       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.